New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
10:00 EDTAIG, ARG, WLH, URBN, TOL, SNTA, PHM, NWBO, MSI, LVNTA, HRZN, FRX, DRH, CHD, ABC, AEO, AMRE, GERNOn The Fly: Analyst Downgrade Summary
AIG (AIG) downgraded to Hold from Buy at Deutsche Bank... AmREIT (AMRE) downgraded to Hold from Buy at Jefferies... American Eagle (AEO) downgraded to Underweight from Equal Weight at Morgan Stanley... AmerisourceBergen (ABC) downgraded to Neutral from Buy at Goldman... Church & Dwight (CHD) downgraded to Neutral from Outperform at Credit Suisse... Clean Harbors (CLH) downgraded to Outperform from Top Pick at RBC Capital... DiamondRock (DRH) downgraded to Underperform from Neutral at BofA/Merrill... Forest Labs (FRX) downgraded to Neutral from Overweight at Piper Jaffray... Horizon Technology (HRZN) downgraded to Underperform at Keefe Bruyette... Liberty Ventures (LVNTA) downgraded to Neutral from Buy at Citigroup... Motorola Solutions (MSI) downgraded to Sell from Neutral at Goldman... Northwest Biotherapeutics (NWBO) downgraded to Perform from Outperform at Oppenheimer... PulteGroup (PHM) downgraded to Neutral from Outperform at Credit Suisse... Synta Pharmaceuticals (SNTA) downgraded to Underperform from Market Perform at BMO Capital... Toll Brothers (TOL) downgraded to Neutral from Outperform at Credit Suisse... Urban Outfitters (URBN) downgraded to Equal Weight from Overweight at Barclays... William Lyon Homes (WLH) downgraded to Neutral from Outperform at Credit Suisse... Airgas (ARG) downgraded to Hold from Buy at BGC Financial... Geron (GERN) downgraded to Neutral from Overweight at Piper Jaffray.
Check below for free stories on AIG;AMRE;AEO;ABC;CHD;DRH;FRX;HRZN;LVNTA;MSI;NWBO;PHM;SNTA;TOL;URBN;WLH;ARG;GERN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 17, 2014
10:00 EDTAIGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:49 EDTAIGAIG initiated with an Outperform at RBC Capital
Target $64.
July 16, 2014
16:16 EDTAMREAmREIT retains Jefferies LLC as financial advisor
Subscribe for More Information
08:20 EDTNWBONorthwest Biotherapeutics completes DCVax-Direct Phase 1 trial recruitment
Northwest Biotherapeutics announced that the Phase I portion of the company's Phase I/II DCVax-Direct clinical trial has completed its 36-patient target recruitment, and the company is now underway with preparations for the Phase II portion of this trial, as well as expansion of DCVax-Direct manufacturing. The Phase I/II trial is testing the safety and activity of DCVax-Direct in various types of cancer. The Phase I portion of the trial has involved testing of 3 different dose levels, and a diverse range of cancers. The patients enrolled in Phase I will continue to receive treatments in accordance with the protocol. With the closing of Phase I, the company is now preparing to initiate the Phase II portion of the trial. This second part of the Phase I/II study will target 24 or more patients in selected cancers. Additional trial sites are being brought on to facilitate and expedite enrollment. The company and its manufacturing partner, Cognate BioServices, are also expanding the manufacturing capacity for DCVax-Direct.
07:04 EDTAIGAIG to receive $650M in cash in Bank of America settlement
Subscribe for More Information
07:02 EDTAIGAIG announces settlement with BofA on residential mortgage related disputes
American International Group (AIG) announced that it has reached a global resolution of its residential mortgage related disputes with Bank of America (BAC). The resolution includes its claims pending in New York and California federal courts related to the creation, offering, and sale of RMBS from which AIG and its subsidiaries suffered losses either directly on their own account or in connection with their participation in AIG’s securities lending program. The resolution also covers AIG’s objections to the $8.5 billion settlement of Countrywide’s mortgage repurchase obligations to various investors, as well as disputes concerning the issuance of mortgage guaranty insurance by AIG’s United Guaranty subsidiaries to Bank of America and Countrywide. Under the terms of the settlement, AIG will receive $650M in cash plus its pro rata share of whatever amount is ultimately paid out to investors in connection with the Countrywide repurchase settlement. In addition, the parties have agreed, subject to the approval of Fannie Mae, Freddie Mac and certain other mortgage holders, to resolve the outstanding mortgage guaranty claims disputes in accordance with agreed-to claims processes and payment formulae.
07:01 EDTAIGAIG announces settlement with BofA on residential mortgage related disputes
Subscribe for More Information
July 15, 2014
07:51 EDTURBNUrban Outfitters weakness a buying opportunity, says Canaccord
Subscribe for More Information
July 11, 2014
12:46 EDTMSIMotorola Solutions downgraded to Neutral from Buy at Tigress Financial
Subscribe for More Information
09:26 EDTAMREAmREIT could see higher bid from Regency, others, says RW Baird
Subscribe for More Information
07:28 EDTHRZNUBS to hold a conference
Subscribe for More Information
July 10, 2014
16:25 EDTAMREOn The Fly: Closing Wrap
Stocks on Wall Street began the session deep in negative territory, as fears about the health of one of Portugal’s largest banks, coupled with weak economic data out of Italy, prompted a sell-off in Europe, which spilled over to the U.S. The major averages moved generally higher after the open, though the early losses proved too much to overcome. The reignited fears about Europe's periphery come just as the U.S. corporate earnings season is set to pick up in earnest next week. ECONOMIC EVENTS: In the U.S., initial jobless claims dropped 11K to 304K in the week ended July 5. Wholesale inventories rose 0.5% in May, while sales edged up 0.7%, which were both a little below expectations. In Europe, concerns about the periphery rose again as the parent company of Portugal's Espirito Santo bank missed a debt payment, leading the country's interest rates higher and equities in the Eurozone lower. Also, Italy's industrial output saw its steepest monthly fall since late 2012, having dropped 1.2% in May. In China, trade performance improved in June but still missed market forecasts. Exports rose 7.2% in June from a year earlier, missing the consensus forecast for a rise of 10.6%, while imports grew 5.5% in the month, versus the 5.8% growth expectation. COMPANY NEWS: Shares of Verizon (VZ) advanced 74c, or 1.51%, to $49.64 to lead the handful of gainers on the Dow Jones Industrial Average. The rise came after Verizon CEO Lowell McAdam said in an interview on CNBC that his company added over 1.4M postpaid subscribers in Q2, with "record" tablet growth and "very strong" smartphone growth. Afterward, Wells Fargo said in a note to investors that the net adds were higher than the firm's recently increased estimate and above Street consensus... Conversely, Home Depot (HD) was the Dow's worst performer, falling $1.33, or 1.65%, to $79.40. After hardwood floors retailer Lumber Liquidators (LL) and farm products retailer Tractor Supply (TSCO) pre-announced weaker than expected Q2 results, Deutsche Bank analyst Mike Baker reduced his estimates for Home Depot and peer Lowe's (LOW), explaining that the comparative sales of those two large home improvement retailers have historically had a positive correlation with those of Tractor Supply and Lumber Liquidators. MAJOR MOVERS: Among the notable gainers was AmREIT (AMRE), which rose $3.25, or 16.93%, to $22.45 after Regency Centers (REG) offered to acquire the company for $22 per share, payable in cash and/or stock. Also higher was Cray (CRAY), which rallied $4.27, or 15.69%, to $31.49 after the company announced it has been awarded a $174M supercomputer deal from the National Nuclear Security Administration. Among the noteworthy losers was sandwich maker Potbelly (PBPB), which plunged $3.68, or 25.12%, to $10.97 after the company's second quarter and fiscal 2014 outlook fell significantly short of analysts' consensus estimates. Also lower was Sarepta Therapeutics (SRPT), which sunk $3.35, or 12.94%, to $22.54 after the company announced data through week 144 from its eteplirsen study in patients with Duchenne muscular dystrophy. INDEXES: The Dow dropped 70.54, or 0.42%, to 16,915.07, the Nasdaq fell 22.83, or 0.52%, to 4,396.20, and the S&P 500 declined 8.15, or 0.41%, to 1,964.68.
16:17 EDTAMREAmREIT confirms receipt of unsolicited proposal from Regency Centers
Subscribe for More Information
15:59 EDTAMREJCP, Schechter call Regency offer for AmREIT 'deeply inadequate'
JCP Investment Management and Joshua Schechter, long-term shareholders in AmREIT (AMRE) with collective ownership of approximately 1.7%, announced that after review and consideration of the unsolicited proposal submitted today to the board of directors of AmREIT by Regency Centers(REG), in which Regency offers to acquire all of the outstanding shares of AmREIT for $22.00 per share in cash or stock, that JCP and Schechter have concluded that the Regency proposal is "deeply inadequate and significantly undervalues the company." JCP Investment and Schechter urge the board to immediately retain a nationally recognized investment bank and commence a process to explore and evaluate all strategic alternatives available, including a sale of the company with a goal of maximizing shareholder value.
14:31 EDTNWBONorthwest Biotherapeutics rises 2.2% to $6.58
Subscribe for More Information
11:49 EDTAMRERegency Centers offer for AmREIT positive, says Wells Fargo
Subscribe for More Information
11:18 EDTURBN, AEOZumiez rallies after raising second quarter outlook
Subscribe for More Information
11:16 EDTAMREAmREIT downgraded to Hold from Buy at Wunderlich
Subscribe for More Information
08:43 EDTAMRERegency Centers announces proposal to acquire AmREIT for $22 per share
Subscribe for More Information
08:42 EDTAMRERegency Centers announces proposal to acquire AmREIT for $22 per share
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use